Prosecution Insights
Last updated: October 04, 2026
Application No. 17/981,405

MULTISENSORY INDEX SYSTEM AND OPERATION METHOD THEREOF

Final Rejection §112§DP
Filed
Nov 05, 2022
Priority
Jul 05, 2022 — RE 10-2022-0082544
Examiner
SCHAETZLE, KENNEDY
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Industry-university Cooperation Foundation Hanyang University
OA Round
4 (Final)
84%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
625 granted / 746 resolved
+13.8% vs TC avg
Moderate +8% lift
Without
With
+8.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
31 currently pending
Career history
775
Total Applications
across all art units

Statute-Specific Performance

§101
11.6%
-28.4% vs TC avg
§103
30.5%
-9.5% vs TC avg
§102
20.2%
-19.8% vs TC avg
§112
19.2%
-20.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 746 resolved cases

Office Action

§112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 9 and 18-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claims 9 and 18, it is unclear if the applicant is attempting to recite an additional emotional care solution besides the music content and vibrational feedback already recited in claims 1 and 10, or if the applicant is simply defining the music and vibrational feedback as an emotional care solution, in which case the claims fail to further limit claims 1 and 10. The examiner will assume the latter (i.e., that the control of music content and vibration recited in claims 1 and 10 is the emotional care solution based on the multi-sensory index) and recommends cancelling claims 9 and 18. In claims 19 and 20, reference to tactile feedback lacks antecedent basis. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 9 and 18-20 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Regarding claims 9 and 18, the vibration feedback now being recited in independent claims 1 and 10 appears to be a specific “emotional care solution” (i.e., one that involves music and vibration). Thus, simply reciting in claims 9 and 18 that an emotional care solution is provided without any further narrowing details on the solution presented in claims 1 and 10, represents a broadening of the claim. It is unclear what further limitation on claims 1 and 10 is being expressed. Regarding claims 19 and 20, independent claims 1 and 10 already recite that the feedback is vibrational (i.e., haptic). It is unclear what further limitation is being expressed. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1, 2, 5, 6, 9-15 and 18-20, as best as can be understood (see above rejections under §112), are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-10 of U.S. Patent No. 12,613,910 in view of the Wikipedia entry entitled “Zero-crossing rate.” The present invention's amended claims are, for the most part, merely broader in scope than the patented claims. Invention ‘910 includes a multisensory index system using a processor (col. 12, line 5) to derive quantitative parameters comprising MFCC and qualitative parameters associated with music content played in a vehicle (col. 12, lines 16-18, 43-51) with vibration feedback outputted through a vehicle seat or neck pillow (col. 12, lines 55-60) based on statistical analysis including fitting a regression model (multi-regression analysis; col. 12, lines 16-18) to data from a user emotion evaluation database (emotion determination model and emotional care correlation) to synchronize the vibration feedback with the music content, and control a sound output device to play the music content in the vehicle while outputting the vibration feedback in the vehicle based on the multisensory index (music played based on emotional care index; col. 12, lines 23, 24, 52-61). Regarding the use of a zero crossing rate ZCR, while use of a ZCR is not recited in the ‘910 invention, determination of the zero crossing rate is a well-known signal processing technique. ZCRs are commonly used in speech recognition, and for music information retrieval, being a key feature to classify percussive sounds and beats/vibrations. (see Wikipedia encyclopedia entry). To utilize this commonly found signal processing technique in the ‘910 invention in order to obtain the recited quantitative parameters would have therefore been considered a matter of obvious design expediency. Once the applicant has received a patent for a species or a more specific embodiment, he is not entitled to a patent for the generic or broader invention (see In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993)). Allowable Subject Matter Claims 7, 8, 16 and 17 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. There does not appear to be any motivation to include the recited five stages in the ‘910 invention. Said stages allow for varied response to the user’s emotional state based on a correlation between quantitative and qualitative parameters. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KENNEDY SCHAETZLE whose telephone number is (571)272-4954. The examiner can normally be reached 2nd Monday of the biweek and W-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David E. Hamaoui can be reached at 571 270 5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KENNEDY SCHAETZLE/Primary Examiner, Art Unit 3796 KJS September 14, 2026
Read full office action

Prosecution Timeline

Show 1 earlier event
Mar 06, 2025
Non-Final Rejection mailed — §112, §DP
Jun 06, 2025
Response Filed
Aug 01, 2025
Final Rejection mailed — §112, §DP
Oct 31, 2025
Request for Continued Examination
Nov 09, 2025
Response after Non-Final Action
Apr 08, 2026
Non-Final Rejection mailed — §112, §DP
Jul 08, 2026
Response Filed
Sep 16, 2026
Final Rejection mailed — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728273
Cardiac Monitoring System with Normally Conducted QRS Complex Identification
2y 11m to grant Granted Sep 08, 2026
Patent 12714350
MEDICAL APPARATUS FOR DIAGNOSTIC AND SITE DETERMINATION OF CARDIAC ARRHYTHMIAS AND METHODS
4y 5m to grant Granted Aug 25, 2026
Patent 12714509
Systems, Devices, Components and Methods for Electroanatomical Mapping of the Heart Using 3D Reconstructions Derived from Biosignals
3y 5m to grant Granted Aug 25, 2026
Patent 12714865
NEUROSTIMULATION SYSTEM WITH FLEXIBLE PATTERNING AND WAVEFORMS
2y 4m to grant Granted Aug 25, 2026
Patent 12685476
SYSTEM AND METHOD FOR SALIENCY DETECTION IN LONG-TERM ECG MONITORING
3y 6m to grant Granted Jul 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
84%
Grant Probability
92%
With Interview (+8.1%)
2y 10m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 746 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month